Cwm LLC Invests $242,000 in Sera Prognostics, Inc. (NASDAQ:SERA)

Cwm LLC bought a new position in Sera Prognostics, Inc. (NASDAQ:SERA) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 40,524 shares of the company’s stock, valued at approximately $242,000.

Several other large investors have also recently made changes to their positions in SERA. Perigon Wealth Management LLC bought a new stake in shares of Sera Prognostics in the fourth quarter worth about $509,000. Vanderbilt University bought a new stake in shares of Sera Prognostics in the fourth quarter worth about $284,000. Finally, Resource Consulting Group Inc. bought a new stake in shares of Sera Prognostics in the fourth quarter worth about $265,000. 54.64% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, insider John J. Boniface sold 24,474 shares of Sera Prognostics stock in a transaction dated Thursday, March 28th. The stock was sold at an average price of $9.04, for a total value of $221,244.96. Following the completion of the transaction, the insider now owns 139,771 shares in the company, valued at $1,263,529.84. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Sera Prognostics news, insider John J. Boniface sold 24,474 shares of the business’s stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $9.04, for a total transaction of $221,244.96. Following the completion of the transaction, the insider now owns 139,771 shares in the company, valued at $1,263,529.84. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Paul Kearney sold 4,984 shares of the business’s stock in a transaction that occurred on Tuesday, February 6th. The shares were sold at an average price of $8.03, for a total value of $40,021.52. Following the transaction, the insider now owns 160,066 shares of the company’s stock, valued at approximately $1,285,329.98. The disclosure for this sale can be found here. Over the last quarter, insiders sold 141,335 shares of company stock worth $1,255,192. Corporate insiders own 15.60% of the company’s stock.

Sera Prognostics Trading Up 2.1 %

SERA opened at $10.85 on Friday. The firm has a market cap of $351.87 million, a P/E ratio of -9.35 and a beta of 1.33. Sera Prognostics, Inc. has a 12 month low of $1.52 and a 12 month high of $12.35. The stock has a 50-day moving average of $9.57 and a 200 day moving average of $6.43.

Sera Prognostics (NASDAQ:SERA) last released its quarterly earnings results on Wednesday, March 20th. The company reported ($0.25) EPS for the quarter, hitting the consensus estimate of ($0.25). The company had revenue of $0.04 million during the quarter, compared to analyst estimates of $0.10 million. Sera Prognostics had a negative return on equity of 45.74% and a negative net margin of 11,843.79%. On average, research analysts forecast that Sera Prognostics, Inc. will post -0.94 earnings per share for the current fiscal year.

About Sera Prognostics

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.